Senvest Management’s Celgene Corp CELG Stock Holding History

Senvest Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-87,500	Closed	-$5.61M	–	58
2018 Q4	$5.61M	Buy	+87,500	New	+$6.46M	0.48%	30

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Senvest Management's CELG Position: Q1 2019 in Review

Senvest Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 87,500 shares — an estimated $5.61M sold.

Senvest Management first reported a position in CELG in Q4 2018 and held it in 1 quarter. The position peaked at $5.61M in Q4 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

Senvest Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
Senvest Management sold 87,500 Celgene Corp shares in Q1 2019, an estimated $5.61M.
Senvest Management first reported a position in Celgene Corp in Q4 2018 and held it in 1 quarter.
Senvest Management's Celgene Corp position peaked at $5.61M in Q4 2018.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Senvest Management's 13F filing for Q1 2019, filed 14 May 2019.